Pricing Log in Create free account

LB Pharmaceuticals Inc (LBRX) vs Nanobiotix S.A. - Sponsored ADR (NBTX)

LB Pharmaceuticals Inc and Nanobiotix S.A. - Sponsored ADR are both Biotechnology companies. LB Pharmaceuticals Inc and Nanobiotix S.A. - Sponsored ADR are of similar size ($1.2B and $1.1B). Across the 8 metrics below, LB Pharmaceuticals Inc leads on 4 and Nanobiotix S.A. - Sponsored ADR on 4.

Valuation

Metric LBRX NBTX Biotechnology median
P/E n/m n/m 8.50
P/S n/m 4,254.38 9.71
P/B 3.33 n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m 3,498.88 9.21
Earnings yield (9.36%) (15.59%) (33.15%)
Free cash flow yield (7.48%) (19.65%) (25.50%)

Profitability

Metric LBRX NBTX Biotechnology median
Gross margin — 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (72.07%) 0.00% (56.36%)
Return on assets (47.38%) 0.00% (48.04%)
Return on invested capital (1,304.79%) 0.00% 0.00%

Growth

Metric LBRX NBTX Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) 98.22% 63.46% 30.26%
Revenue growth, 5-year CAGR — 66.64% 9.41%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric LBRX NBTX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 15.08 1.44 4.72
Net debt to EBITDA 9.90 5.66 0.96

Dividend

Metric LBRX NBTX Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric LBRX NBTX Biotechnology median
Market cap 1.18b 1.13b 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack